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Abstract 
Near infrared spectroscopy (NIRS) is a non-invasive method to monitor cerebral 
haemodynamics. Used either alone or in combination with other non-invasive 
methods such as transcranial Doppler sonography, this technique is well suited for 
use in cerebrovascular research in ageing. Reproducibility of NIRS, however, has 
only been determined in neonates and adults. We applied controlled desaturation 
(the O2-method) to measure the cerebral blood volume (CBV) with NIRS in 16 
healthy subjects aged 65 to 88. This method uses deoxygenated haemoglobin (the 
concentration of which is manipulated by desaturation) as an intravascular tracer 
for NIRS. We determined repeatability (between tests interval: 2 min), short-term 
reproducibility (intervals of 20 and 40 min) and long-term reproducibility (interval > 
2 weeks). We found a coefficient of variation (CV) of 12.5% for repeatability and a 
CV of 11.7% for short-term reproducibility. The CV for long-term reproducibility 
was 15%. We conclude that NIRS can reproducibly measure CBV in subjects aged 
65 and older, using the O2-method. In this group of healthy subjects, this method 
was well tolerated. 
 Introduction 
With advancing age, global cerebral blood flow declines.1 Moreover, there is an 
increasing prevalence of factors such as orthostatic hypotension and postprandial 
hypotension that could further impair perfusion of the brain.2-4 In clinical practice, 
these findings can lead to dizziness, loss of consciousness or syncope and 
cerebral ischaemia.3 Research in this field requires continuous haemodynamic 
monitoring of both systemic blood pressure and cerebral perfusion. Magnetic 
resonance imaging (MRI) and positron emission tomography (PET) are two 
important techniques to investigate cerebral haemodynamics, but these methods 
are limited to monitoring in the supine position, and may have limited availability. 
Near infrared spectroscopy (NIRS) offers non-invasive monitoring of cerebral 
haemodynamics with high temporal resolution at low cost.5 It can easily be 
adapted to allow continuous monitoring during a 90-min postprandial test, or 
during head-up tilt or active standing. NIRS can measure beat-to-beat variations in 
the concentrations of oxygenated (O2Hb) and deoxygenated (HHb) haemoglobin. 
We have previously shown that these measurements are reproducible in healthy 
elderly subjects.6 In addition, we have demonstrated that NIRS-recorded changes 
in O2Hb and HHb, brought about by finger tapping, correlated well with changes in 
BOLD-signal recorded by fMRI.7  
 Techniques have been developed in neonatal research that enable NIRS to 
measure the more intuitive haemodynamic parameters, cerebral blood flow (CBF) 
and cerebral blood volume (CBV).8-12 In contrast with the situation in neonates, in 
adults only CBV can be measured reproducibly.9,10 CBV is affected by changes in 
cerebrovascular dilatation, arterial-to-venous-transit time and CBF.13 To measure 
CBV, O2Hb and HHb are used as an intravascular tracer, or ‘dye’. A gradual 
decrease in the fraction of inspired oxygen results in a slow desaturation of 
haemoglobin, hence its name ‘the O2-method’.11 The reproducibility of this method 
has been examined in neonates and adults, and its internal validity has been 
tested in an animal model, but no data are available for subjects above the age of 
65.10,11,14 Because ageing is associated with reduced cerebral blood flow, brain 
atrophy and changes in respiratory physiology, this method may be less reliable in 
older subjects. We designed this study to test the reproducibility of CBV 
measurements in subjects between 65 and 90 years old. 
 
 
 
 
Methods 
Study design 
CBV was measured in two cortical regions: the frontal and frontoparietal cortex. It 
has previously been demonstrated that the frontal cortex is susceptible to 
deoxygenation in orthostatic hypotension.3 The repeatability, short-term and long-
term reproducibility were tested. Repeatability was assessed in three sets of 
repeated CBV measurements (see figure 1). Each set consisted of two identical 
desaturation periods with a normoxic interval of 1 min. Short-term reproducibility 
was assessed by inserting a 20 min interval between the first and the second set. 
During this interval, the subjects remained in a supine position. Between the 
second and the third set, we used a longer interval of 40 min. After 20 min, we 
performed an intervention that is likely to be used in future studies assessing CBV 
with NIRS. This intervention consisted of a 60◦ head-up tilt test for a period of 5 
min. The purpose was to test the possible effect of a tilt-test procedure on optode 
position and fixation. Movement of the optodes due to tilting could have a negative 
effect on the reproducibility of the CBV measurements following this tilt test. We 
waited 20 min before measuring CBV, to cancel out the effect that tilting itself has 
on CBV. Finally, long-term reproducibility was tested by repeating a CBV test after 
an interval of two or more weeks. All measurements were performed and analysed 
by the same researcher (JC). 
 This protocol was approved by the Ethics Committee of our institution. 
 
Figure 1. Graphical overview of the experiment.  
 
 
 
The bottom half shows the SaO2-curve, where the desaturation episodes can easily be identified. The 
upper half of the graph shows the parameters measured by NIRS. Oxygenated haemoglobin decreases 
during desaturation (peaks facing downwards); deoxygenated haemoglobin rises during desaturation 
(upward peaks); and total haemoglobin (which represents the sum of the previous parameters) should 
remain constant during desaturation (a straight line). 
 Subjects 
We recruited 16 healthy volunteers responding to a newspaper announcement, 12 
men, 4 women, mean age 73 years, range 68–87. All subjects were examined by 
a geriatrician. They were leading an active and independent life, had no history of 
cardiovascular or cerebrovascular disease, had a normal cognitive screening (mini 
mental state examination score >24 and normal clock drawing test), and used no 
medication. They had normal ECGs, and normal duplex examination of the carotid 
and vertebral arteries. All subjects gave their written informed consent. 
 
CBV measurements 
We used a continuous wave NIRS instrument (Oxymon, Artinis Medical Systems, 
The Netherlands). A detailed description of the materials and methods used to 
measure CBV has been published previously.10 The distance between the 
transmitter and the receivers was 5.5 cm to assure deep enough penetration of the 
infrared light into the brain to exclude substantial contamination from the extra-
cerebral circulation. The probes were held in place by a custom-made elastic 
headband and were applied to the skin with light pressure. We applied a fixed 
differential path length factor of 6.6 (corresponding to age 50) in all subjects.15 This 
factor corrects for the distance that the light travels through the cerebral tissue. No 
data are available on the actual variation of the differential path length factor with 
age above the age of 50. For the purpose of this reproducibility study, however, 
this is of little significance. 
 All experiments were performed in the morning. Beat-to-beat arterial pressure 
was recorded using a finger plethysmograph (Finapres, Ohmeda 2300, USA). 
Arterial saturation (SaO2) was recorded with a pulse oximeter (N200 Nellcor 
Puritan Benett, USA) with a reflectance sensor attached to the forehead, and end 
tidal CO2 (etCO2) was monitored using a capnograph (N1000, Nellcor Puritan 
Benett, USA). All analogue signals were synchronized and stored together with the 
NIRS data on a PC for off-line analysis. 
 During desaturation, the subjects were asked to breathe through a face mask, 
and hypoxia was induced using a stepwise computer controlled reduction of the 
inspired oxygen fraction (FiO2) by changing an O2/N2 gas mixture (Bronckhorst 
Hitec, Ruurlo, The Netherlands). We aimed for a gradual decrease in SaO2 of 10% 
below baseline within 3 to 5 min, after which FiO2 was immediately increased to 
33%. As a result of this, SaO2 returned to normal values within 10 to 30 s. 
 
 
CBV analysis 
CBV analysis was performed off-line using a software application written inMatlab 
(Oxysoft, Artinis Medical Systems, The Netherlands). The start and end of each 
desaturation episode were visually identified from the graphic representation of the 
changes in [O2Hb], [HHb] and SaO2 (see figure 2). The theoretical explanation of 
CBV calculation from these data has been described in detail before.10-12 In short, 
the concentrations of [O2Hb] and [HHb] measured by NIRS vary with the 
concentration of cerebral haemoglobin [cHb] and its absorptive property, which 
depends on its oxygenation state (SaO2). Because total cerebral haemoglobin 
remains constant during desaturation, [O2Hb] and [HHb] will change equally but in 
opposite direction, and their average is used in the equation as the differential 
haemoglobin signal (Hbdiff = ([O2Hb] − [HHb])/2). [cHb] is then derived from the 
relationship of the change in Hbdiff and SaO2. This relationship can be calculated 
using the slope method, which applies linear regression (Hbdiff = slope כ SaO2 + 
constant) to determine the slope, which equals [cHb]. CBV is derived from [cHb] by 
multiplying with a constant k that incorporates brain density, cerebral-to-large-
vessel haematocritratio and unit conversion, and this result is divided by the 
subjects haemoglobin [Hb] concentration: 
CBV(mL 100 g−1) = k כ [cHb]/[Hb] 
 
Statistical analysis 
All CBV tests were processed regardless of their quality, except for those 
instances where CBV could not be calculated due to a disturbance in either the 
NIRS signal or the pulse oximetry signal, mostly due to motion artefacts or 
disconnection of the probes leading to signal loss. These instances are reported 
as missing values or uninterpretable tests. 
 For repeatability, we compared the two measurements in each of the three sets. 
For reproducibility, we compared the average values for the three sets. We 
calculated coefficients of variation (CV) and two-tailed Pearson correlation 
coefficients. Differences were tested with a paired sample t-test. 
 The overall CBV for each subject was calculated as the mean of the three CBV 
sets. Because of the small size of the group and the unevenly spread ages, we did 
not investigate the correlation between age or gender and CBV. 
 We determined mean values for blood pressure and etCO2 measurements 
during 3 min of baseline recording and during 1 min at the end of the first 
desaturation episode, and compared these values using a paired-sample t-test. 
 
Figure 2. Example of a CBV measurement. 
  
 
The lower part of the graph shows the saturation curve, identifying the period of desaturation. The upper 
part shows the effect of desaturation on the parameters measured by NIRS, oxygenated and deoxygenated 
haemoglobin. The dotted lines mark the manually chosen points for the calculation of CBV using the slope 
method (see the text for details). 
 
Results 
Group values (mean ± SD) for cHb were 28.3 ± 9 μmol L−1. The results of the CBV 
measurements are summarized in table 1. The CBV for the whole group was 0.98 
± 0.38 mL 100 g−1. There was a small and non-significant difference between the 
CBV in the first and last set (−0.1 mL 100 g−1, p = 0.2). Mean etCO2 was 34.7 ± 
3.6 mmHg during baseline and 34.8 ± 4.2 mmHg during desaturation. The average 
mean arterial pressure (MAP) was 75.7 ± 9.5 mmHg during baseline and 78.9 ± 
9.9 mmHg during desaturation (p = 0.034).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Summary of individual data for age, gender and CBV values. This table provides age and CBV 
values for all subjects, as well as mean values for the whole group. Three sets of two CBV measurements 
were performed with intervals of 20 min, 40 min and more than 1 week. Each CBV value represents the 
average of the two CBV measurements in that particular set. Missing values are uninterpretable CBV 
measurements. 
 
 Age  CBV (mL 100 g−1) 
Subject Gender (years)  Baseline 20 min 40 min ≥1 week 
1 Female 70  0.52 0.56 0.51 0.52 
2 Female 68  1.28 0.96 1.11 0.47 
3 Female 70  0.64 0.86 0.81 0.61 
4 Female 73  0.77 0.80 0.77 0.89 
5 Male 69  1.20 1.06 1.05 1.17 
6 Male 70  Missing 0.63 0.54 1.04 
7 Male 68  1.06 1.25 1.39 1.23 
8 Male 75  0.84 0.77 0.80 1.00 
9 Male 69  1.17 1.29 1.11 1.00 
10 Male 82  1.21 1.08 0.91 1.03 
11 Male 74  0.87 0.64 0.50 Missing 
12 Male 70  1.30 1.32 1.10 1.47 
13 Male 73  1.76 1.27 1.56 1.33 
14 Male 75  1.16 1.46 1.42 1.35 
15 Male 75  0.65 0.68 0.58 1.17 
16 Male 87  0.84 0.68 0.59 0.88 
 Mean 73  1.02 0.96 0.92 1.01 
 SD 5.2  0.33 0.29 0.34 0.30 
 Min 68  0.52 0.56 0.50 0.47 
 Max 87  1.76 1.46 1.56 1.47 
 
The results for repeatability are demonstrated in table 2. We found no difference in 
repeatability between the three sets, or between the two measurement sites, and 
therefore all measurements were pooled. The CV for these pooled data was 
12.5% (95% CI: 9.3–15.8%). A Bland–Altman plot is presented in figure 3.  
 
Table 2. Coefficients of variation (CV) for repeated CBV tests, expressed as mean values with 95% 
confidence interval. The first pair of CBV tests (CBV-set 1) was recorded at the baseline, the second (CBV-
set 2) was performed after 20 min of supine rest, and the third (CBV-set 3) after 40 min of supine rest, 
interrupted midway by a tilt test for 5 min. Missing values are reported as the percentage of the total 
number of CBV-sets (48) that were collected. 
 
Optode 
position 
Missing 
values 
CBV-set 1 CV (%) 
(95% CI)
CBV-set 2 CV (%) 
(95% CI)
CBV-set 3 CV (%) 
(95% CI) 
Frontal 8 11.8 (5.9–17.6) 11.7 (7.4–16.1) 11.0 (5.2–16.8)
Parietal 15 10.9 (6.3–15.5) 14.3 (5–23.6) 17.3 (8.7–25.9)
 
 
 
Figure 3. Repeatability of CBV tests.  
 
  
 
Analysis as proposed by Bland and Altman of repeated CBV tests calculated using the slope method (see 
the text for details). In 16 subjects, six sets of two repeated (interval: 1 min) CBV measurements were 
performed. The average of these two measurements is plotted against their difference 
 
The mean CV for the third set of repeated CBV tests, which was obtained 20 min 
after a tilt table intervention, was not significantly different from that of previous 
CBV sets. Pearson’s correlation coefficient for the repeated tests was R = 0.81, p 
< 0.001. 11 out of 96 sets (11%) could not be analysed because either or both 
CBV tests were uninterpretable.  
 For short-term reproducibility, we found a good correlation between the three 
CBV values (R > 0.8, p = 0.01), and the CV was 11.7% (95% CI: 8.3–15%). For 
the CBV values obtained on different days (with an interval of two or more weeks), 
correlation was acceptable (R=0.5, p=0.05) and the CV was 15% (95% CI 5–
25%). A Bland–Altman plot for long-term reproducibility is presented in figure 4. 
 The quality of a measurement using the slope method can be expressed by the 
linear correlation coefficient (r2) of the relationship between the changes in Hbdiff 
and SaO2. Mean r2 for our measurements was 0.92 ± 0.05. We found a correlation 
between the goodness of fit (a high value for r2) and the CV (R = 0.3, p = 0.05). All 
CBV values with r2 > 0.95 had a CV of 10% or less. 
 
Figure 4. Long-term reproducibility of CBV measurements.  
 
 
 
Analysis as proposed by Bland and Altman. In 16 subjects, CBV was determined twice with an interval of 
more than 2 weeks. The average of the two CBV values is plotted against their difference. 
 
Discussion 
The main finding of our study is that CBV measurements with NIRS can be 
performed with the same reliability in old subjects as they can in other age groups. 
Repeatability in our study resulted in a CV of 12.5%, which is almost equivalent to 
the CV of 11.7% that was found for this method in adults and the CV of 11.5% that 
was found in neonates.10,11 Of note, the study of Van de Ven et al was performed 
in our institution using identical equipment and methodology. These investigators 
have discussed the differences with reproducibility results from studies using other 
methodology.10  
 An important new outcome of our study is that, even with a prolonged interval of 
several weeks, measurements of CBV with NIRS in this age group of healthy 
elderly subjects were reproducible with a CV of 15%, and showed an acceptable 
correlation. Over such a period, individual CBV is subject to considerable 
physiological change. The option to perform repeated measurements of CBV over 
time with a non-invasive method like NIRS offers an interesting perspective for 
cerebrovascular research. 
  The reproducibility of CBV measurements with NIRS in our study compares 
favourably to other methods. For example, PET measures CBV with a CV of 20% 
16, and MRI measures CBV with a CV of 14% 17. 
 The fact that we did not validate our NIRS measurements with a second method 
to determine CBV is a limitation in the design of this study. However, even though 
there are several methods available to measure CBV, none of these can actually 
serve as a gold standard. Haemodynamic measurements with NIRS in animals, 
neonates and adults have been compared with MRI, immunolabelling, jugular 
venous occlusion plethysmography and PET.18-21 The correlation between the two 
methods studied varied from very poor to excellent. Only one of these studies, 
comparing NIRS with MRI, actually used the desaturation method to determine 
CBV. In this study, the group mean value for CBV obtained with NIRS was similar 
to that found with MRI, but intra-individual correlation between the two methods 
was poor.21 We judged that validation with a second neuroimaging tool that cannot 
serve as a gold standard would yield little extra information for the purpose of our 
reproducibility study. 
 A potential problem with the desaturation method is that it could influence CBV. 
Prolonged hypoxia, especially around or below a SaO2 of 80%, can induce 
vasodilatation and increase CBF and CBV. On the other hand, desaturation could 
produce compensatory hyperventilation, which causes vasoconstriction and 
reduces CBF. In our study, we found no evidence for hyperventilation during 
desaturation, as etCO2 remained stable. Blood pressure rose slightly during 
desaturation, which is consistent with previous investigations. Because we 
performed paired CBV measurements with a short interval, any substantial effect 
of the desaturation procedure itself on CBV would result in the second CBV 
measurement being systematically higher or lower than the first. We did not find 
such an effect in our study. In addition, we constantly monitored the total 
haemoglobin concentration measured by NIRS, which did not change during our 
desaturation procedures. 
 We did not investigate the possible effects of altered brain geometry with ageing 
on the outcome of CBV measurements. For instance, brain atrophy with ageing 
would increase the depth of the cerebral tissue relative to the probes. This could 
unfavourably affect the relative contribution of extracerebral tissue to the NIRS 
signal. In order to investigate this, a method comparing different source-detector 
distances would be needed. Kohri et al.22 for example demonstrated that with 
source-detector distances of 3 cm, the cerebral tissue contributed to 55% of the 
signal, versus 69% when using a 4 cm distance. We did not investigate these 
aspects in this study for several reasons. First, we wished to compare results 
directly with the previous study by Van de Ven et al in younger subjects, using an 
identical technique. Second, the source-detector distance used with the Oxymon-
device is 5.5 cm, which is larger than is generally available in other NIRS devices, 
and represents the optimal distance for this device to minimize noise from extra-
cerebral tissues. Third, a previous study in our laboratory has measured the depth 
between NIRS optodes and cerebral cortical tissue using MRI in a small group of 
young (35 ± 9 years) and ageing (73 ± 3 years) subjects, and found no evidence 
for an increase with ageing.7  
 Possibly related to this matter is the finding of low CBV values in our group. 
Even though estimation of individual values for CBV was not the primary focus of 
this study, this finding merits further discussion. For comparison, mean CBV 
determined by PET was 3.8 ± 0.7 mL 100 g−1 in a group with a mean age of 51.8 
(±15.1) years.16 The study of Van de Ven et al, using NIRS, found a mean CBV 
value of 3.66 ± 0.82 mL 100 g−1 in a group of adults with a mean age of 31 ± 10 
years. Future studies are needed to further investigate the low CBV values we 
found in our age group. Despite similar brain geometry in young and ageing 
subjects, a reduction with ageing in the deoxyhaemoglobin response to cortical 
activation was apparent both with NIRS and fMRI in a previous study.7 One of 
many possible explanations for this finding is a reduced cortical haemoglobin 
content with ageing. A future study using different source-detector distances and 
measuring brain geometrics with MRI may serve to confirm in a larger group that 
there is no evidence for reduced brain tissue sample due to brain atrophy. In 
addition, a study investigating a larger, intermediate age group may demonstrate if 
a true reduction of CBV measured by NIRS age occurs with advancing age. 
 
Conclusion 
The O2-method to measure changes in CBV with NIRS can be applied in subjects 
aged 65 years and older. Despite many possible sources of variation in older 
subjects, including reduced global cerebral perfusion, brain atrophy and altered 
respiratory physiology, we found that reproducibility in our study was comparable 
to investigations in younger subjects. We conclude that NIRS is a safe and reliable 
tool to monitor changes in CBV in cerebrovascular research in the ageing 
population. 
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